Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers
Molecular Therapy: OncologyPeritoneal metastases from gastrointestinal malignancies present difficult management decisions, with options consisting primarily of systemic chemotherapy or major surgery with or without hyperthermic intraperitoneal chemotherapy.
Aleksandra Sikora +4 more
doaj +1 more source
Bases and foundations of the treatment of peritoneal carcinomatosis: Review article [PDF]
, 2016 Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis.
Barrios Sánchez, P. +3 more
core
BMC Cancer, 2006 Background In selected patients with peritoneal carcinomatosis from colorectal cancer prognosis can be improved by hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery.
Dimmler A +4 more
doaj +1 more source
BRIP-1 germline mutation and its role in colon cancer: presentation of two case reports and review of literature. [PDF]
, 2019 BackgroundHereditary colon cancer is characterized by the inheritance of an abnormal gene mutation which predisposes to malignancy. Recent advances in genomic medicine have identified mutations in "novel" genes as conferring an increased risk of ...
Ali, Mir +2 more
core
Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC [PDF]
, 2018 Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric ...
Brandl, Andreas +5 more
core +1 more source
World Journal of Surgical Oncology, 2017 Background Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis. Case presentation We report here a long-term survival case of PPPSC with postoperative lung metastasis.
Jingping Yuan +3 more
doaj +1 more source
Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin [PDF]
, 2015 Combining chemotherapy and targeted therapies has resulted in an enhanced survival in metastatic colorectal cancer (mCRC) patients. However, the result of this palliative treatment in patients with metachronous peritoneal carcinomatosis (PC) remains ...
Creemers, G.J.M. (Geert-Jan) +5 more
core +3 more sources
Translational Oncology, 2016 OBJECTIVE: To assess the effect of hyperthermic intraperitoneal chemotherapy (HIPEC) to eradicate intraperitoneal free cancer cells and to explore the feasibility of cytological cure for peritoneal carcinomatosis (PC).
Zhonghe Ji +5 more
doaj +1 more source
Primary malignant mixed Müllerian tumor arising from the mesorectum with a synchronous ovarian cancer: a case report and review of the literature [PDF]
, 2011 Introduction Extragenital malignant mixed Müllerian tumor is an extremely rare presentation of malignant mixed Müllerian tumor, especially when combined with a synchronous ovarian cancer. Case presentation
Chuang-Chi Huang +4 more
core +1 more source
Efficacy and safety of intraperitoneal chemotherapy for pancreatic cancer
BMC SurgeryPancreatic cancer is a highly aggressive cancer with unfavorable prognosis despite the therapeutic interventions. Intraperitoneal chemotherapy has recently shown potential outcomes in the presence of peritoneal metastases.
Dorsa Safari +2 more
doaj +1 more source